IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein.
Chronic bullous disease of childhood (CBDC) is an autoimmune blistering disease occurring in prepubertal children. Both CBDC and its adult counter-part, linear IgA bullous dermatosis (LABD), are characterized by linear deposition of IgA along the cutaneous basement membrane zone (BMZ). Circulating IgA antibody in LABD has been found to bind to a 97-kDa BMZ antigen, whereas the antigen in CBDC has not been well characterized. The purpose of this study was to evaluate the immunoreactivity of BMZ IgA antibodies in a series of CBDC patients. We evaluated 12 sera from patients with CBDC with circulating IgA anti-BMZ antibodies on indirect immunofluorescence (IIF), which stained the epidermal side of split skin with titers ranging from 1:20 to 1:640. Immunoblotting was performed against two preparations of BMZ proteins: one enriched with the two bullous pemphigoid antigens (BP230, BP180) and one enriched with the LABD antigen (LABD97). Eight of the twelve sera reacted with a 97-kDa protein that co-migrated with the protein detected in many LABD sera. The intensity of the reaction on immunoblot correlated with serum antibody titers. There was no consistent pattern of reactivity of the IgA anti-BMZ antibodies with either the BP230 or BP180 antigens, although two sera reacted with several higher molecular mass proteins (160-200 kDa). The significance of this reactivity was examined with immunoblotting using BMZ-affinity-purified antibodies, and ELF using nitrocellulose-eluted antibodies. One serum also contained anti-BMZ IgA antibodies that reacted with a 180-kDa protein, corresponding to BP180. We conclude that IgA antibodies in CBDC sera recognize a 97-kDa BMZ antigen present on the epidermal side of BMZ split skin that co-migrates with the antigen previously identified in LABD. These findings suggest that CBDC and LABD are the immunologically related disorders occurring in different age groups.
Zone
J J
JJ
Medicine Service, Section of Dermatology, Veterans Affairs Medical Center, Salt Lake City, Utah, USA.
Taylor
T B
TB
Kadunce
D P
DP
Chorzelski
T P
TP
Schachner
L A
LA
Huff
J C
JC
Meyer
L J
LJ
Petersen
M J
MJ
D000906:Antibodies / Q000276:immunology*; D000941:Antigens / Q000276:immunology; D001485:Basement Membrane / Q000276:immunology*; D015153:Blotting, Western; D002648:Child; D002908:Chronic Disease; D003101:Collodion; D004817:Epidermis / Q000276:immunology; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D015151:Immunoblotting; D007120:Immunochemistry / Q000379:methods; D007070:Immunoglobulin A / Q000276:immunology*; D008565:Membrane Proteins / Q000276:immunology*; D012872:Skin Diseases, Vesiculobullous / Q000097:blood / Q000276:immunology*
D000906:Antibodies; D000941:Antigens; D007070:Immunoglobulin A; D008565:Membrane Proteins; D003101:Collodion